Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
von Bueren, AO; von Hoff, K; Benesch, M; Rutkowski, S.
Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.
Klin Padiatr. 2009; 221(6): 396-397.
Doi: 10.1055/s-0029-1238278
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Benesch Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Age Factors -
- Antineoplastic Agents, Phytogenic - administration and dosage
- Antineoplastic Combined Chemotherapy Protocols - therapeutic use
- Cerebellar Neoplasms - drug therapy
- Child -
- Child, Preschool -
- Cisplatin - administration and dosage
- Combined Modality Therapy -
- Disease-Free Survival -
- Dose-Response Relationship, Drug -
- Female -
- Humans -
- Lomustine - administration and dosage
- Male -
- Medulloblastoma - drug therapy
- Neoadjuvant Therapy -
- Nervous System Diseases - chemically induced
- Prospective Studies -
- Radiotherapy, Adjuvant -
- Risk Factors -
- Vincristine - administration and dosage